Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea.
Eunju KimHyun Woong LeeSoon Sun KimEileen YoonEun Sun JangJong-In ChangYoung Youn ChoGi Hyeon SeoHyung Joon KimPublished in: Alimentary pharmacology & therapeutics (2023)
TAF-treated patients with CHB had a significantly lower risk of osteoporotic fracture than TDF-treated patients.